212
Views
19
CrossRef citations to date
0
Altmetric
Discontinued Drugs Perspective

Discontinued psychiatric drugs in 2008

, , , & , MD FRCPC
Pages 1431-1443 | Published online: 28 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Magdalena J Ślusarz. (2015) Vasopressin V1a and V1b receptor modulators: a patent review (2012 – 2014). Expert Opinion on Therapeutic Patents 25:6, pages 711-722.
Read now
Jayaprakasam Bolleddula, Kevin DeMent, James P. Driscoll, Philip Worboys, Patrick J. Brassil & David L. Bourdet. (2014) Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. Drug Metabolism Reviews 46:3, pages 379-419.
Read now
JA Roper, A-M O'Carroll, WS Young$suffix/text()$suffix/text() & SJ Lolait. (2011) The vasopressin Avpr1b receptor: Molecular and pharmacological studies. Stress 14:1, pages 98-115.
Read now

Articles from other publishers (16)

Jonathan Livingstone-Banks, Thomas R Fanshawe, Kyla H Thomas, Annika Theodoulou, Anisa Hajizadeh, Lilian Hartman & Nicola Lindson. (2023) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2023:6.
Crossref
Jonathan Livingstone-Banks, Thomas R Fanshawe, Kyla H Thomas, Annika Theodoulou, Anisa Hajizadeh, Lilian Hartman & Nicola Lindson. (2023) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Wallace Chan, Jiansheng Wu, Eric Bell & Yang Zhang. 2022. GPCRs as Therapeutic Targets. GPCRs as Therapeutic Targets 388 423 .
Elena V. Radchenko, Olga A. Sykhovskaya, Timofey L. Galankin, Aleksei S. Kolbin & Maria A. Smirnova. (2018) Network meta-analysis: a comparison of effectiveness and safety of partial agonists of nicotinic acetylcholine receptors varenicline and cytisine for smoking cessation. Reviews on Clinical Pharmacology and Drug Therapy 16:4, pages 19-32.
Crossref
Jan M. Deussing & Alon Chen. (2018) The Corticotropin-Releasing Factor Family: Physiology of the Stress Response. Physiological Reviews 98:4, pages 2225-2286.
Crossref
Gerard J. Marek. 2017. Drug Selectivity. Drug Selectivity 335 367 .
R Zhang, M Asai, C E Mahoney, M Joachim, Y Shen, G Gunner & J A Majzoub. (2016) Loss of hypothalamic corticotropin-releasing hormone markedly reduces anxiety behaviors in mice. Molecular Psychiatry 22:5, pages 733-744.
Crossref
Stephan Hjorth. (2016) Looking back (and in)to the future: A personal reflection on ‘Serotonin autoreceptor function and antidepressant drug action’ (Hjorth et al., 2000). Journal of Psychopharmacology 30:11, pages 1129-1136.
Crossref
Kate Cahill, Nicola Lindson-Hawley, Kyla H Thomas, Thomas R Fanshawe & Tim Lancaster. (2016) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews.
Crossref
Elena Dale, Alan L. Pehrson, Theepica Jeyarajah, Yan Li, Steven C. Leiser, Gennady Smagin, Christina K. Olsen & Connie Sanchez. (2015) Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function. CNS Spectrums 21:2, pages 143-161.
Crossref
Mary Ann C. Stephens, Mary E. McCaul & Gary S. Wand. 2014. Neurobiology of Alcohol Dependence. Neurobiology of Alcohol Dependence 429 450 .
Nebojsa Jasnic, Jelena Djordjevic, Predrag Vujovic, Iva Lakic, Sinisa Djurasevic & Gordana Cvijic. (2013) The effect of vasopressin 1b receptor (V1bR) blockade on HPA axis activity in rats exposed to acute heat stress. Journal of Experimental Biology 216:12, pages 2302-2307.
Crossref
Joanna K. Soczynska, Rodrigo B. Mansur, Elisa Brietzke, Walter Swardfager, Sidney H. Kennedy, Hanna O. Woldeyohannes, Alissa M. Powell, Marena S. Manierka & Roger S. McIntyre. (2012) Novel therapeutic targets in depression: Minocycline as a candidate treatment. Behavioural Brain Research 235:2, pages 302-317.
Crossref
Taka-aki Koshimizu, Kazuaki Nakamura, Nobuaki Egashira, Masami Hiroyama, Hiroshi Nonoguchi & Akito Tanoue. (2012) Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems. Physiological Reviews 92:4, pages 1813-1864.
Crossref
Guy Griebel & Florian Holsboer. (2012) Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?. Nature Reviews Drug Discovery 11:6, pages 462-478.
Crossref
Kate Cahill, Lindsay F Stead & Tim Lancaster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.